Aging Biology · Cellular FunctionFOXO4-DRI
D-Retro-Inverso Senolytic Peptide
Experimental peptide investigated in cellular-senescence research.
EU Delivery: 2–4 Business Days
About this peptide
FOXO4-DRI is a precision-engineered senolytic peptide that selectively removes senescent cells — the damaged, inflammatory 'zombie' cells that accumulate with age and drive tissue decline.
By disrupting the FOXO4–p53 interaction that keeps senescent cells alive, FOXO4-DRI triggers their selective removal while leaving healthy cells untouched. Clearing this cellular deadweight relieves chronic inflammation, restores tissue function and rejuvenates the ageing body.
Users report improvements in energy, physical function, skin quality and hair regrowth — the classic signature of successful senolytic action.
Research profile
Removes senescent cells while sparing healthy ones.
Cuts the chronic inflammation driving age-related decline.
Restores function across skin, muscle and organs.
D-retro-inverso design for stability and potency.
Research areas
- Clears senescent 'zombie' cells
- Reduces chronic inflammation
- Restores tissue function and vitality
- Improves skin quality and hair growth
- Central tool in modern senolytic protocols
- Highly stable, precision-engineered peptide
Specifications
- Class
- D-retro-inverso peptide
- Presentation
- 10 mg lyophilised vial
- Analytical
- Batch tested · HPLC verified
- Storage
- 2–8 °C, protect from light
Verified customer reviews
No reviews yet. Reviews come only from customers with a delivered order.
For research use only. Not intended for human or veterinary therapeutic use.
